UnitedHealth Group Optum Rx — Gain (Loss) on Portfolio Actions remained flat by 0.0% to -$375.00M in Q4 2025 compared to the prior quarter. This decline may warrant attention — for this metric, higher values are generally preferred.
A gain indicates successful divestiture of assets at a premium, while a loss suggests impairment or unfavorable terms during portfolio optimization.
This metric represents the net financial impact resulting from strategic adjustments to the business segment's asset por...
Similar to 'Net gain/loss on disposal of assets' or 'Non-operating portfolio adjustments' found in other large healthcare services or pharmacy benefit management firms.
unh_segment_optum_rx_gain_loss_on_portfolio_actions| FY'25 | |
|---|---|
| Value | -$1.50B |